Bleakley Financial Group »

Disc Medicine shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $215k 3.7k 57.76

More positions owned by Bleakley Financial Group

Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Sprott Physical Gold & Silve Tr Unit (CEF)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)
Ishares Silver Tr Ishares (SLV)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Bleakley Financial Group

Top funds holding Disc Medicine

Atlas Venture Life Science Advisors
Paradigm Biocapital Advisors
OrbiMed Advisors
Perceptive Advisors
Frazier Life Sciences Management
Vanguard Group
T. Rowe Price Associates
Deerfield Management Company
Henderson Group
Alliancebernstein
Caption Management
5AM Venture Management
Franklin Resources
Citadel Advisors
Ikarian Capital

View all funds holding Disc Medicine